Surgery to Improve Survival in Isolated Tricuspid Regurgitation

Patients with isolated tricuspid regurgitation (i.e., who have no associated left-sided valve disease) are frequently treated conservatively. In many cases, valve disease is highly symptomatic, even with the optimization of medical treatment; however, an invasive strategy is seldom proposed.

Cirugía para mejorar la sobrevida en insuficiencia tricuspidea aislada

The aim of this work was to measure the impact of surgery on isolated tricuspid regurgitation compared to medical treatment alone.

Researchers conducted a retrospective analysis of 3276 patients with pure tricuspid regurgitation who were included in an echocardiography database between November 2001 and March 2016. All-cause mortality for patients who underwent surgery versus those who received medical treatment alone was compared using propensity score matching to balance baseline differences.

Among 3276 patients with isolated tricuspid regurgitation, only 171 (5%) underwent surgery (143 for valve repair and 28 for valve replacement). The remaining 3105 patients were managed with medical treatment.


Read also: Do NOACs Result in Any Benefit in TAVR?


Upon analysis, there were no differences between the patients who underwent surgery and those who did not (hazard ratio [HR]: 1.34; p = 0.288).

In the surgical subgroup, there were no differences between repair and replacement surgery patients (HR: 1.53; p = 0.254).

Conclusion

Patients with isolated tricuspid regurgitation do not benefit from surgery in terms of long-term survival compared to medical treatment alone.

Original Title: Surgery Does Not Improve Survival in Patients With Isolated Severe Tricuspid Regurgitation.

Reference: Andrea L. Axtell et al. J Am Coll Cardiol 2019;74:715–25.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

Atrial functional mitral regurgitation (aFMR), which results from atrial dilation without significant left ventricular dysfunction, accounts for approximately one-third of mitral regurgitation (MR) cases...

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical challenges remain that may affect long-term outcomes....

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Percutaneous Tricuspid Valve Replacement with Lux-Valve

Tricuspid regurgitation (TR) is a condition associated with poor quality of life, frequent hospitalizations due to heart failure, and increased mortality, even under optimal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Percutaneous Treatment of Atrial Functional Mitral Regurgitation

Atrial functional mitral regurgitation (aFMR), which results from atrial dilation without significant left ventricular dysfunction, accounts for approximately one-third of mitral regurgitation (MR) cases...

ACURATE Neo2 Underexpansion: Prevalence and Clinical Implications

While transcatheter aortic valve replacement (TAVR) provides durable clinical benefits across a wide range of patients, technical challenges remain that may affect long-term outcomes....

Spontaneous Left Main Dissection: Clinical Characteristics, management and Outcomes

Courtesy of Dr. Juan Manuel Pérez. Spontaneous left main dissection in an uncommon, and potentially life-threatening, cause of acute MI. The aim of this study,...